文献速递肿瘤 PET/CT核素与放射性配体治疗

恶性淋巴瘤的现代PET引导放射治疗计划与治疗

Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma.
PubMed 文献 · Semin Nucl Med · 2022-10-12

本文综述FDG-PET/CT影像在恶性淋巴瘤分期、疗效评估及放疗计划中的关键作用,重点介绍ILROG、NCCN及新版德国S3指南推荐的现代标准治疗,并讨论从大面积均匀照射野向基于功能影像生物学反应评估的个体化复杂设野转变所带来的副作用进一步降低与治疗现代化,同时涉及相关局限与未来挑战。

要点

  • PET/CT影像在恶性淋巴瘤分期分层和疗效评估中起关键作用。
  • 功能影像及一线化疗后疾病活动再评估使放疗野大小和毒性显著改善。
  • ILROG等国际专家组制定影像用于治疗计划的优化指南。

核心结论

  • 基于功能影像生物学反应评估的个体化设野替代大面积均匀照射野,使淋巴瘤放疗副作用进一步降低并推动治疗现代化。

研究设计与样本

  • 本文为综述,总结FDG-PET影像用于恶性淋巴瘤放疗计划的历史与未来发展,并讨论相关局限与挑战。

主要发现

  • 上世纪治疗手段的持续改进使患者预后从致死性结局改善为高疾病控制率和长期生存。
  • PET/CT影像在分期分层和治疗反应评估中起关键作用。
  • 对放疗而言,功能影像及一线化疗后疾病活动再评估使治疗野大小和毒性获得重大改善。
  • 从均匀大面积治疗体积向考虑基于功能影像生物学反应评估的复杂个体化设野转变,使副作用进一步降低。

关键数值与推荐

  • 国际淋巴瘤放疗肿瘤组(ILROG)等国际专家组制定影像用于治疗计划的优化使用指南。
  • 本文讨论ILROG、国家综合癌症网络(NCCN)及新近更新的德国S3指南推荐的当代标准治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Malignant lymphoma comprises a broad spectrum of diverse entities originating from different types of lymphocytes. In the last century, successive improvements of treatment possibilities have led to an continuous amelioration of patient prognosis from lethal outcome to high rates of disease control and long-term survivors. PET/CT-based imaging plays a key role in stratification of stage and treatment response. Especially for radiotherapy, an essential treatment modality for lymphoma patients, functional imaging and the reevaluation of disease activity after frontline chemotherapy has led to major improvements regarding size of treatment fields and toxicity. International expert groups like the International Lymphoma Radiation Oncology Group (ILROG) develop guidelines for the optimal use of imaging for treatment planning. The shift from uniform large-field treatment volumes to complex individual setups taking into account biological response-assessments based on functional imaging resulted in a further de-escalation of side effects and modernization of lymphoma treatment. This paper aims to summarize the use of FDG-PET-imaging for radiation therapy planning in malignant lymphoma in the context of historic and future developments, as well as associated limitations and challenges ahead. We will discuss the contemporary standard of care as recommended by international expert guidelines like the ILROG, the national comprehensive cancer network (NCCN), as well as the newly updated German S3-guidelines.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pepper NB, Oertel M, Rehn S, et al. Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma. Semin Nucl Med. 2022. PMID: 36241473. doi:10.1053/j.semnuclmed.2022.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。